BIO Bio-Rad Laboratories, Inc.
$380.99▲ +2.30%
Healthcare
Other
After hours
$380.99▲ +0.00%
Oct 27, 4:15 PM ET
Volume 167.2K
Avg Volume (10D) 225.4K
Key Metrics & Fundamentals
Market Cap
$10.19B
P/E Ratio
48.3
Div Yield
0.00%
52W Range
236.73 - 396.23
% vs 50 MA
1.91%
% vs 200 MA
21.91%
RSI-14
60.4
MACD Histogram
+1.7900
Beta (1Y vs SPY)
0.75
Free Cash Flow
$66.70M
Gross Rev
$651.00M
Gross Profit
$345.80M
EBITDA
$136.80M
COGS
$305.20M
Operating Exp
$273.20M
Operating Income
$72.60M
EBIT
$72.60M
Pretax Income
$542.10M
Net Income
$371.40M
EPS (Diluted)
13.85
Price & Volume History
Loading chart…
Recent News
BIO (BIO) vs. TMO and DHR: Can Activist Pressure Close Bio-Rad’s Valuation Discount?
Insider Monkey · Oct 27, 2026 10:58 AM ET
Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026
Business Wire · Oct 14, 2026 9:00 AM ET
Cell Isolation / Cell Separation - Global Strategic Business Report: Secure Share of a US$42.8 Billion Market by 2030 as BD Biosciences, Beckman Coulter, Bio-Rad and Thermo Fisher Accelerate
GlobeNewswire · Oct 14, 2026 4:10 AM ET
Global Cell-Based Assays Market Report 2026-2030 | Secure Share in the $54.79 Billion Market Growing at 13.3% as Promega, Bio-Rad, PerkinElmer, and Danaher Scale AI Automation
GlobeNewswire · Oct 14, 2026 4:04 AM ET
Global Protein Labeling Market Report 2026: Size, Share, Trends, and 2030 Forecast | Capture a $4.89 Billion Market as Thermo Fisher, Merck, Bio-Rad, and Abcam Scale Automation
GlobeNewswire · Oct 13, 2026 4:11 AM ET
Global Bioconjugation Reagents Market Report 2026: Size, Trends, and Forecast to 2030 | Accelerate ADC and Click Chemistry Growth with Thermo Fisher, Merck, Danaher, and Bio-Rad
GlobeNewswire · Oct 13, 2026 4:02 AM ET
Neogen (NEOG) Q1 Earnings and Revenues Beat Estimates
Zacks · Oct 6, 2026 4:15 PM ET
Recombinant Proteins Manufacturing Services Market Report Released; 19.7% CAGR as revenue nearly triples from $5.2B to $15.3B by 2030; benchmark WuXi Biologics, GenScript, Bio-Rad, ACROBiosystems and Syngene amid tariff disruption
GlobeNewswire · Oct 1, 2026 4:02 AM ET
Why Bio Rad Laboratories (BIO) Is Back In The Spotlight
Simply Wall St. · Sep 30, 2026 8:09 PM ET
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
Zacks · Sep 28, 2026 10:03 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BIO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.